See more : PT. Arkora Hydro Tbk (ARKO.JK) Income Statement Analysis – Financial Results
Complete financial analysis of West Island Brands Inc. (WIB.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of West Island Brands Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Cepton, Inc. (CPTN) Income Statement Analysis – Financial Results
- MDxHealth SA (MXDHF) Income Statement Analysis – Financial Results
- Karo Pharma AB (publ) (KARBF) Income Statement Analysis – Financial Results
- TotalEnergies SE (TTE) Income Statement Analysis – Financial Results
- Gowest Gold Ltd. (GWA.V) Income Statement Analysis – Financial Results
West Island Brands Inc. (WIB.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.westislandbrands.com
About West Island Brands Inc.
West Island Brands Inc. engages in the medical marijuana business. It offers IONIC MIST, a spray mist that captures and neutralizes cannabis smoke odors. The company was formerly known as Matica Enterprises Inc. and changed its name to West Island Brands Inc. in October 2021. West Island Brands Inc. was incorporated in 2007 and is based in Toronto, Canada.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 2.33M | 121.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 4.95M | 305.77K | 34.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | -2.63M | -184.35K | -34.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | -112.97% | -151.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 400.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 2.33M | 1.47M | 1.34M | 5.48M | 4.94M | 693.40K | 644.05K | 595.83K | 388.51K | 284.96K | 335.12K | 173.28K | 159.75K | 107.94K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 225.90K | 78.43K | 45.90K | 1.09M | 601.50K | 101.61K | 23.29K | 21.78K | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 2.33M | 1.47M | 1.34M | 5.48M | 5.02M | 739.30K | 1.73M | 1.20M | 490.12K | 308.24K | 356.90K | 173.28K | 159.75K | 107.94K | 2.33K |
Other Expenses | 0.00 | 205.38K | 113.34K | 34.23K | 83.33K | 695.00K | 0.00 | 0.00 | 28.73K | 76.70K | 41.13K | -3.33K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 2.54M | 1.58M | 1.38M | 5.45M | 5.02M | 739.30K | 1.73M | 1.63M | 566.81K | 349.37K | 356.90K | 173.28K | 159.75K | 107.94K | 2.33K |
Cost & Expenses | 0.00 | 7.49M | 1.88M | 1.38M | 5.45M | 5.02M | 739.30K | 1.73M | 1.63M | 566.81K | 349.37K | 356.90K | 173.28K | 159.75K | 107.94K | 2.33K |
Interest Income | 0.00 | 6.20K | 51.53K | 88.75 | 1.40K | 0.00 | 0.00 | 0.00 | 0.00 | 907.00 | 1.67K | 1.90K | 0.00 | 0.00 | 0.00 | |
Interest Expense | 0.00 | 75.93K | 54.46K | 0.00 | 1.40K | 1.73M | 4.93M | 3.46M | 1.54M | 907.00 | 1.67K | 63.59K | 0.00 | 0.00 | 10.00 | |
Depreciation & Amortization | 228.49K | 205.38K | 113.34K | 34.23K | -105.25K | -424.04K | -1.22M | -2.06M | -3.08M | -731.82K | -613.74K | 1.67K | 154.06K | -25.00K | 0.00 | -4.66K |
EBITDA | 0.00 | -4.86M | -8.35M | -1.94M | -5.26M | -3.90M | -483.73K | -3.14M | -1.46M | -165.01K | -264.37K | -355.24K | -19.22K | -184.75K | -107.94K | -2.33K |
EBITDA Ratio | 0.00% | -208.67% | 4,574.13% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 0.00 | -5.06M | 5.44M | -691.77K | -5.45M | -5.02M | 739.30K | 1.73M | 1.63M | 566.81K | 349.37K | -358.57K | -173.28K | -159.75K | -107.94K | 2.33K |
Operating Income Ratio | 0.00% | -217.50% | 4,480.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 0.00 | -122.34K | -6.75M | -550.19K | 193.42K | 1.12M | -152.41K | -712.39K | -161.01K | -31.82K | -85.32 | -1.67K | -154.06K | -25.00K | 0.00 | 0.00 |
Income Before Tax | 0.00 | -5.14M | -8.51M | -1.98M | -5.26M | -3.90M | -994.87K | -3.20M | -1.83M | -968.62K | -433.47K | -360.24K | -327.34K | -134.75K | 0.00 | 0.00 |
Income Before Tax Ratio | 0.00% | -221.16% | -7,011.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 175.65K | 7.20M | 686.65K | -188.58K | -1.12M | 1.73M | 4.93M | 3.46M | 1.54M | 781.93K | -3.33K | 152.16K | 25.00K | 107.94K | 4.66K |
Net Income | 0.00 | -5.32M | -15.72M | -2.66M | -5.26M | -3.90M | -994.87K | -3.20M | -1.83M | -968.62K | -433.47K | -355.24K | -389.03K | -184.75K | -107.94K | -2.34K |
Net Income Ratio | 0.00% | -228.71% | -12,944.90% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | -0.50 | -1.48 | -0.25 | -0.54 | -0.61 | -0.26 | -1.16 | -1.29 | -1.26 | -1.15 | -1.03 | -1.50 | -1.15 | -0.91 | 0.00 |
EPS Diluted | 0.00 | -0.50 | -1.48 | -0.25 | -0.54 | -0.61 | -0.26 | -1.16 | -1.29 | -1.26 | -1.15 | -1.03 | -1.50 | -1.15 | -0.91 | 0.00 |
Weighted Avg Shares Out | 0.00 | 10.68M | 10.62M | 10.51M | 9.74M | 6.38M | 3.84M | 2.76M | 1.42M | 767.18K | 376.91K | 345.30K | 258.98K | 160.00K | 118.07K | 1.39M |
Weighted Avg Shares Out (Dil) | 0.00 | 10.68M | 10.62M | 10.51M | 9.74M | 6.38M | 3.84M | 2.76M | 1.42M | 767.18K | 376.91K | 345.30K | 258.98K | 160.00K | 118.07K | 1.39M |
Source: https://incomestatements.info
Category: Stock Reports